nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—urinary bladder cancer—testicular cancer	0.256	1	CtDrD
Valrubicin—Epirubicin—testicular cancer	0.19	0.519	CrCtD
Valrubicin—Doxorubicin—testicular cancer	0.176	0.481	CrCtD
Valrubicin—TOP2A—Epirubicin—testicular cancer	0.0549	0.433	CbGbCtD
Valrubicin—TOP2A—Etoposide—testicular cancer	0.0428	0.337	CbGbCtD
Valrubicin—Idarubicin—Epirubicin—testicular cancer	0.0406	0.173	CrCrCtD
Valrubicin—Doxorubicin—Epirubicin—testicular cancer	0.0406	0.173	CrCrCtD
Valrubicin—Daunorubicin—Epirubicin—testicular cancer	0.0406	0.173	CrCrCtD
Valrubicin—Epirubicin—Doxorubicin—testicular cancer	0.0375	0.16	CrCrCtD
Valrubicin—Daunorubicin—Doxorubicin—testicular cancer	0.0375	0.16	CrCrCtD
Valrubicin—Idarubicin—Doxorubicin—testicular cancer	0.0375	0.16	CrCrCtD
Valrubicin—TOP2A—Doxorubicin—testicular cancer	0.0292	0.23	CbGbCtD
Valrubicin—Local reaction—Bleomycin—testicular cancer	0.000394	0.0247	CcSEcCtD
Valrubicin—Cystitis noninfective—Chlorambucil—testicular cancer	0.000275	0.0173	CcSEcCtD
Valrubicin—Cystitis—Chlorambucil—testicular cancer	0.000272	0.0171	CcSEcCtD
Valrubicin—Anorectal discomfort—Etoposide—testicular cancer	0.000269	0.0169	CcSEcCtD
Valrubicin—Bladder pain—Chlorambucil—testicular cancer	0.000255	0.016	CcSEcCtD
Valrubicin—Rectal tenesmus—Epirubicin—testicular cancer	0.000221	0.0139	CcSEcCtD
Valrubicin—Cystitis noninfective—Bleomycin—testicular cancer	0.000213	0.0134	CcSEcCtD
Valrubicin—Cystitis—Bleomycin—testicular cancer	0.00021	0.0132	CcSEcCtD
Valrubicin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000207	0.188	CbGdCrCtD
Valrubicin—Rectal tenesmus—Doxorubicin—testicular cancer	0.000205	0.0128	CcSEcCtD
Valrubicin—Ageusia—Cisplatin—testicular cancer	0.000198	0.0124	CcSEcCtD
Valrubicin—Bladder pain—Bleomycin—testicular cancer	0.000197	0.0124	CcSEcCtD
Valrubicin—Urinary incontinence—Ifosfamide—testicular cancer	0.00018	0.0113	CcSEcCtD
Valrubicin—Proctalgia—Epirubicin—testicular cancer	0.000176	0.011	CcSEcCtD
Valrubicin—Proctalgia—Doxorubicin—testicular cancer	0.000163	0.0102	CcSEcCtD
Valrubicin—Pneumonia—Chlorambucil—testicular cancer	0.000158	0.00994	CcSEcCtD
Valrubicin—Body temperature increased—Carboplatin—testicular cancer	0.000154	0.00968	CcSEcCtD
Valrubicin—Anorectal discomfort—Epirubicin—testicular cancer	0.000151	0.00946	CcSEcCtD
Valrubicin—Local reaction—Epirubicin—testicular cancer	0.000149	0.00934	CcSEcCtD
Valrubicin—Anorectal discomfort—Doxorubicin—testicular cancer	0.00014	0.00875	CcSEcCtD
Valrubicin—Local reaction—Doxorubicin—testicular cancer	0.000138	0.00864	CcSEcCtD
Valrubicin—Pelvic pain—Epirubicin—testicular cancer	0.000136	0.0085	CcSEcCtD
Valrubicin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000131	0.118	CbGdCrCtD
Valrubicin—TOP2A—Teniposide—Etoposide—testicular cancer	0.00013	0.118	CbGdCrCtD
Valrubicin—TOP2A—Podofilox—Etoposide—testicular cancer	0.00013	0.118	CbGdCrCtD
Valrubicin—Urinary retention—Ifosfamide—testicular cancer	0.000129	0.00806	CcSEcCtD
Valrubicin—Pelvic pain—Doxorubicin—testicular cancer	0.000125	0.00787	CcSEcCtD
Valrubicin—Pneumonia—Bleomycin—testicular cancer	0.000123	0.00769	CcSEcCtD
Valrubicin—Haematuria—Bleomycin—testicular cancer	0.000116	0.00729	CcSEcCtD
Valrubicin—Pneumonia—Dactinomycin—testicular cancer	0.000114	0.00717	CcSEcCtD
Valrubicin—Anaemia—Chlorambucil—testicular cancer	0.000114	0.00714	CcSEcCtD
Valrubicin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.000112	0.101	CbGdCrCtD
Valrubicin—Irritability—Cisplatin—testicular cancer	0.000111	0.00698	CcSEcCtD
Valrubicin—Dysuria—Ifosfamide—testicular cancer	0.000109	0.00685	CcSEcCtD
Valrubicin—Pollakiuria—Ifosfamide—testicular cancer	0.000108	0.00677	CcSEcCtD
Valrubicin—Hyperglycaemia—Ifosfamide—testicular cancer	0.000105	0.00661	CcSEcCtD
Valrubicin—Pneumonia—Ifosfamide—testicular cancer	0.000105	0.00657	CcSEcCtD
Valrubicin—Ill-defined disorder—Vinblastine—testicular cancer	0.000105	0.00656	CcSEcCtD
Valrubicin—Anaemia—Vinblastine—testicular cancer	0.000104	0.00654	CcSEcCtD
Valrubicin—Ageusia—Epirubicin—testicular cancer	0.000102	0.00638	CcSEcCtD
Valrubicin—Malaise—Vinblastine—testicular cancer	0.000102	0.00638	CcSEcCtD
Valrubicin—Haematuria—Ifosfamide—testicular cancer	9.93e-05	0.00623	CcSEcCtD
Valrubicin—Discomfort—Vinblastine—testicular cancer	9.49e-05	0.00595	CcSEcCtD
Valrubicin—Ageusia—Doxorubicin—testicular cancer	9.42e-05	0.00591	CcSEcCtD
Valrubicin—Vasodilation procedure—Epirubicin—testicular cancer	9.38e-05	0.00589	CcSEcCtD
Valrubicin—Vasodilation—Epirubicin—testicular cancer	9.38e-05	0.00589	CcSEcCtD
Valrubicin—Nocturia—Epirubicin—testicular cancer	8.89e-05	0.00558	CcSEcCtD
Valrubicin—Ill-defined disorder—Bleomycin—testicular cancer	8.84e-05	0.00554	CcSEcCtD
Valrubicin—Anaemia—Bleomycin—testicular cancer	8.81e-05	0.00552	CcSEcCtD
Valrubicin—Vasodilation—Doxorubicin—testicular cancer	8.68e-05	0.00545	CcSEcCtD
Valrubicin—Vasodilation procedure—Doxorubicin—testicular cancer	8.68e-05	0.00545	CcSEcCtD
Valrubicin—Cystitis noninfective—Methotrexate—testicular cancer	8.61e-05	0.0054	CcSEcCtD
Valrubicin—Malaise—Bleomycin—testicular cancer	8.59e-05	0.00539	CcSEcCtD
Valrubicin—Cystitis—Methotrexate—testicular cancer	8.51e-05	0.00534	CcSEcCtD
Valrubicin—Feeling abnormal—Chlorambucil—testicular cancer	8.28e-05	0.00519	CcSEcCtD
Valrubicin—Pneumonia—Etoposide—testicular cancer	8.28e-05	0.00519	CcSEcCtD
Valrubicin—Ill-defined disorder—Dactinomycin—testicular cancer	8.24e-05	0.00517	CcSEcCtD
Valrubicin—Nocturia—Doxorubicin—testicular cancer	8.22e-05	0.00516	CcSEcCtD
Valrubicin—Gastrointestinal pain—Chlorambucil—testicular cancer	8.21e-05	0.00515	CcSEcCtD
Valrubicin—Anaemia—Dactinomycin—testicular cancer	8.21e-05	0.00515	CcSEcCtD
Valrubicin—Myalgia—Bleomycin—testicular cancer	8.11e-05	0.00509	CcSEcCtD
Valrubicin—Chest pain—Bleomycin—testicular cancer	8.11e-05	0.00509	CcSEcCtD
Valrubicin—Cystitis noninfective—Epirubicin—testicular cancer	8.05e-05	0.00505	CcSEcCtD
Valrubicin—Discomfort—Bleomycin—testicular cancer	8.01e-05	0.00503	CcSEcCtD
Valrubicin—Malaise—Dactinomycin—testicular cancer	8.01e-05	0.00503	CcSEcCtD
Valrubicin—Bladder pain—Methotrexate—testicular cancer	7.97e-05	0.005	CcSEcCtD
Valrubicin—Cystitis—Epirubicin—testicular cancer	7.96e-05	0.00499	CcSEcCtD
Valrubicin—Abdominal pain—Chlorambucil—testicular cancer	7.94e-05	0.00498	CcSEcCtD
Valrubicin—Body temperature increased—Chlorambucil—testicular cancer	7.94e-05	0.00498	CcSEcCtD
Valrubicin—Blood urea increased—Epirubicin—testicular cancer	7.78e-05	0.00488	CcSEcCtD
Valrubicin—Feeling abnormal—Vinblastine—testicular cancer	7.59e-05	0.00476	CcSEcCtD
Valrubicin—Myalgia—Dactinomycin—testicular cancer	7.56e-05	0.00474	CcSEcCtD
Valrubicin—Ill-defined disorder—Ifosfamide—testicular cancer	7.55e-05	0.00474	CcSEcCtD
Valrubicin—Gastrointestinal pain—Vinblastine—testicular cancer	7.53e-05	0.00472	CcSEcCtD
Valrubicin—Anaemia—Ifosfamide—testicular cancer	7.53e-05	0.00472	CcSEcCtD
Valrubicin—Discomfort—Dactinomycin—testicular cancer	7.47e-05	0.00469	CcSEcCtD
Valrubicin—Bladder pain—Epirubicin—testicular cancer	7.45e-05	0.00468	CcSEcCtD
Valrubicin—Cystitis noninfective—Doxorubicin—testicular cancer	7.45e-05	0.00467	CcSEcCtD
Valrubicin—Cystitis—Doxorubicin—testicular cancer	7.37e-05	0.00462	CcSEcCtD
Valrubicin—Malaise—Ifosfamide—testicular cancer	7.34e-05	0.00461	CcSEcCtD
Valrubicin—Abdominal pain—Vinblastine—testicular cancer	7.28e-05	0.00456	CcSEcCtD
Valrubicin—Asthenia—Chlorambucil—testicular cancer	7.21e-05	0.00452	CcSEcCtD
Valrubicin—Blood urea increased—Doxorubicin—testicular cancer	7.2e-05	0.00452	CcSEcCtD
Valrubicin—Pruritus—Chlorambucil—testicular cancer	7.11e-05	0.00446	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Bleomycin—testicular cancer	7.08e-05	0.00444	CcSEcCtD
Valrubicin—Chest pain—Ifosfamide—testicular cancer	6.93e-05	0.00435	CcSEcCtD
Valrubicin—Myalgia—Ifosfamide—testicular cancer	6.93e-05	0.00435	CcSEcCtD
Valrubicin—Flatulence—Cisplatin—testicular cancer	6.92e-05	0.00434	CcSEcCtD
Valrubicin—Bladder pain—Doxorubicin—testicular cancer	6.9e-05	0.00433	CcSEcCtD
Valrubicin—Diarrhoea—Chlorambucil—testicular cancer	6.87e-05	0.00431	CcSEcCtD
Valrubicin—Discomfort—Ifosfamide—testicular cancer	6.85e-05	0.0043	CcSEcCtD
Valrubicin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	6.81e-05	0.0617	CbGdCrCtD
Valrubicin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	6.81e-05	0.0617	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Epirubicin—testicular cancer	6.81e-05	0.0617	CbGdCrCtD
Valrubicin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	6.61e-05	0.00414	CcSEcCtD
Valrubicin—Asthenia—Vinblastine—testicular cancer	6.6e-05	0.00414	CcSEcCtD
Valrubicin—Ill-defined disorder—Cisplatin—testicular cancer	6.51e-05	0.00408	CcSEcCtD
Valrubicin—Anaemia—Cisplatin—testicular cancer	6.49e-05	0.00407	CcSEcCtD
Valrubicin—Feeling abnormal—Bleomycin—testicular cancer	6.41e-05	0.00402	CcSEcCtD
Valrubicin—Vomiting—Chlorambucil—testicular cancer	6.39e-05	0.00401	CcSEcCtD
Valrubicin—Malaise—Cisplatin—testicular cancer	6.33e-05	0.00397	CcSEcCtD
Valrubicin—Diarrhoea—Vinblastine—testicular cancer	6.3e-05	0.00395	CcSEcCtD
Valrubicin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	6.3e-05	0.0571	CbGdCrCtD
Valrubicin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	6.3e-05	0.0571	CbGdCrCtD
Valrubicin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	6.3e-05	0.0571	CbGdCrCtD
Valrubicin—Back pain—Etoposide—testicular cancer	6.22e-05	0.0039	CcSEcCtD
Valrubicin—Body temperature increased—Bleomycin—testicular cancer	6.15e-05	0.00386	CcSEcCtD
Valrubicin—Irritability—Methotrexate—testicular cancer	6.1e-05	0.00383	CcSEcCtD
Valrubicin—Dizziness—Vinblastine—testicular cancer	6.09e-05	0.00382	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	6.05e-05	0.0038	CcSEcCtD
Valrubicin—Myalgia—Cisplatin—testicular cancer	5.98e-05	0.00375	CcSEcCtD
Valrubicin—Feeling abnormal—Dactinomycin—testicular cancer	5.98e-05	0.00375	CcSEcCtD
Valrubicin—Nausea—Chlorambucil—testicular cancer	5.97e-05	0.00374	CcSEcCtD
Valrubicin—Ill-defined disorder—Etoposide—testicular cancer	5.97e-05	0.00374	CcSEcCtD
Valrubicin—Anaemia—Etoposide—testicular cancer	5.94e-05	0.00373	CcSEcCtD
Valrubicin—Gastrointestinal pain—Dactinomycin—testicular cancer	5.93e-05	0.00372	CcSEcCtD
Valrubicin—Discomfort—Cisplatin—testicular cancer	5.9e-05	0.0037	CcSEcCtD
Valrubicin—Vomiting—Vinblastine—testicular cancer	5.85e-05	0.00367	CcSEcCtD
Valrubicin—Malaise—Etoposide—testicular cancer	5.8e-05	0.00364	CcSEcCtD
Valrubicin—Headache—Vinblastine—testicular cancer	5.77e-05	0.00362	CcSEcCtD
Valrubicin—Abdominal pain—Dactinomycin—testicular cancer	5.73e-05	0.0036	CcSEcCtD
Valrubicin—Body temperature increased—Dactinomycin—testicular cancer	5.73e-05	0.0036	CcSEcCtD
Valrubicin—Asthenia—Bleomycin—testicular cancer	5.58e-05	0.0035	CcSEcCtD
Valrubicin—Pruritus—Bleomycin—testicular cancer	5.5e-05	0.00345	CcSEcCtD
Valrubicin—Feeling abnormal—Ifosfamide—testicular cancer	5.48e-05	0.00343	CcSEcCtD
Valrubicin—Chest pain—Etoposide—testicular cancer	5.47e-05	0.00343	CcSEcCtD
Valrubicin—Nausea—Vinblastine—testicular cancer	5.47e-05	0.00343	CcSEcCtD
Valrubicin—Gastrointestinal pain—Ifosfamide—testicular cancer	5.43e-05	0.00341	CcSEcCtD
Valrubicin—Discomfort—Etoposide—testicular cancer	5.41e-05	0.00339	CcSEcCtD
Valrubicin—Body temperature increased—Ifosfamide—testicular cancer	5.25e-05	0.00329	CcSEcCtD
Valrubicin—Abdominal pain—Ifosfamide—testicular cancer	5.25e-05	0.00329	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Cisplatin—testicular cancer	5.22e-05	0.00327	CcSEcCtD
Valrubicin—Asthenia—Dactinomycin—testicular cancer	5.2e-05	0.00326	CcSEcCtD
Valrubicin—Dysuria—Methotrexate—testicular cancer	5.17e-05	0.00324	CcSEcCtD
Valrubicin—Diarrhoea—Dactinomycin—testicular cancer	4.96e-05	0.00311	CcSEcCtD
Valrubicin—Pneumonia—Methotrexate—testicular cancer	4.96e-05	0.00311	CcSEcCtD
Valrubicin—Vomiting—Bleomycin—testicular cancer	4.94e-05	0.0031	CcSEcCtD
Valrubicin—Rash—Bleomycin—testicular cancer	4.9e-05	0.00307	CcSEcCtD
Valrubicin—Dermatitis—Bleomycin—testicular cancer	4.9e-05	0.00307	CcSEcCtD
Valrubicin—Dysuria—Epirubicin—testicular cancer	4.84e-05	0.00303	CcSEcCtD
Valrubicin—Pollakiuria—Epirubicin—testicular cancer	4.78e-05	0.003	CcSEcCtD
Valrubicin—Asthenia—Ifosfamide—testicular cancer	4.77e-05	0.00299	CcSEcCtD
Valrubicin—Feeling abnormal—Cisplatin—testicular cancer	4.72e-05	0.00296	CcSEcCtD
Valrubicin—Pruritus—Ifosfamide—testicular cancer	4.7e-05	0.00295	CcSEcCtD
Valrubicin—Haematuria—Methotrexate—testicular cancer	4.7e-05	0.00295	CcSEcCtD
Valrubicin—Hyperglycaemia—Epirubicin—testicular cancer	4.67e-05	0.00293	CcSEcCtD
Valrubicin—Pneumonia—Epirubicin—testicular cancer	4.64e-05	0.00291	CcSEcCtD
Valrubicin—Nausea—Bleomycin—testicular cancer	4.62e-05	0.0029	CcSEcCtD
Valrubicin—Vomiting—Dactinomycin—testicular cancer	4.61e-05	0.00289	CcSEcCtD
Valrubicin—Rash—Dactinomycin—testicular cancer	4.57e-05	0.00287	CcSEcCtD
Valrubicin—Diarrhoea—Ifosfamide—testicular cancer	4.55e-05	0.00285	CcSEcCtD
Valrubicin—Body temperature increased—Cisplatin—testicular cancer	4.53e-05	0.00284	CcSEcCtD
Valrubicin—Urinary tract infection—Epirubicin—testicular cancer	4.48e-05	0.00281	CcSEcCtD
Valrubicin—Dysuria—Doxorubicin—testicular cancer	4.48e-05	0.00281	CcSEcCtD
Valrubicin—Pollakiuria—Doxorubicin—testicular cancer	4.42e-05	0.00277	CcSEcCtD
Valrubicin—Haematuria—Epirubicin—testicular cancer	4.4e-05	0.00276	CcSEcCtD
Valrubicin—Dizziness—Ifosfamide—testicular cancer	4.39e-05	0.00276	CcSEcCtD
Valrubicin—Feeling abnormal—Etoposide—testicular cancer	4.32e-05	0.00271	CcSEcCtD
Valrubicin—Hyperglycaemia—Doxorubicin—testicular cancer	4.32e-05	0.00271	CcSEcCtD
Valrubicin—Nausea—Dactinomycin—testicular cancer	4.31e-05	0.0027	CcSEcCtD
Valrubicin—Pneumonia—Doxorubicin—testicular cancer	4.29e-05	0.00269	CcSEcCtD
Valrubicin—Gastrointestinal pain—Etoposide—testicular cancer	4.29e-05	0.00269	CcSEcCtD
Valrubicin—Vomiting—Ifosfamide—testicular cancer	4.22e-05	0.00265	CcSEcCtD
Valrubicin—Rash—Ifosfamide—testicular cancer	4.19e-05	0.00263	CcSEcCtD
Valrubicin—Dermatitis—Ifosfamide—testicular cancer	4.19e-05	0.00263	CcSEcCtD
Valrubicin—Abdominal pain—Etoposide—testicular cancer	4.15e-05	0.0026	CcSEcCtD
Valrubicin—Body temperature increased—Etoposide—testicular cancer	4.15e-05	0.0026	CcSEcCtD
Valrubicin—Urinary tract infection—Doxorubicin—testicular cancer	4.15e-05	0.0026	CcSEcCtD
Valrubicin—Asthenia—Cisplatin—testicular cancer	4.11e-05	0.00258	CcSEcCtD
Valrubicin—Oedema peripheral—Epirubicin—testicular cancer	4.08e-05	0.00256	CcSEcCtD
Valrubicin—Haematuria—Doxorubicin—testicular cancer	4.07e-05	0.00255	CcSEcCtD
Valrubicin—Nausea—Ifosfamide—testicular cancer	3.95e-05	0.00248	CcSEcCtD
Valrubicin—Diarrhoea—Cisplatin—testicular cancer	3.92e-05	0.00246	CcSEcCtD
Valrubicin—Oedema peripheral—Doxorubicin—testicular cancer	3.77e-05	0.00237	CcSEcCtD
Valrubicin—Asthenia—Etoposide—testicular cancer	3.77e-05	0.00236	CcSEcCtD
Valrubicin—Back pain—Methotrexate—testicular cancer	3.73e-05	0.00234	CcSEcCtD
Valrubicin—Pruritus—Etoposide—testicular cancer	3.71e-05	0.00233	CcSEcCtD
Valrubicin—Vomiting—Cisplatin—testicular cancer	3.64e-05	0.00228	CcSEcCtD
Valrubicin—Rash—Cisplatin—testicular cancer	3.61e-05	0.00227	CcSEcCtD
Valrubicin—Dermatitis—Cisplatin—testicular cancer	3.61e-05	0.00226	CcSEcCtD
Valrubicin—Diarrhoea—Etoposide—testicular cancer	3.59e-05	0.00225	CcSEcCtD
Valrubicin—Ill-defined disorder—Methotrexate—testicular cancer	3.57e-05	0.00224	CcSEcCtD
Valrubicin—Anaemia—Methotrexate—testicular cancer	3.56e-05	0.00223	CcSEcCtD
Valrubicin—Flatulence—Epirubicin—testicular cancer	3.55e-05	0.00223	CcSEcCtD
Valrubicin—Back pain—Epirubicin—testicular cancer	3.49e-05	0.00219	CcSEcCtD
Valrubicin—Malaise—Methotrexate—testicular cancer	3.47e-05	0.00218	CcSEcCtD
Valrubicin—Dizziness—Etoposide—testicular cancer	3.47e-05	0.00218	CcSEcCtD
Valrubicin—Nausea—Cisplatin—testicular cancer	3.4e-05	0.00213	CcSEcCtD
Valrubicin—Ill-defined disorder—Epirubicin—testicular cancer	3.34e-05	0.0021	CcSEcCtD
Valrubicin—Vomiting—Etoposide—testicular cancer	3.34e-05	0.00209	CcSEcCtD
Valrubicin—Anaemia—Epirubicin—testicular cancer	3.33e-05	0.00209	CcSEcCtD
Valrubicin—Rash—Etoposide—testicular cancer	3.31e-05	0.00208	CcSEcCtD
Valrubicin—Dermatitis—Etoposide—testicular cancer	3.31e-05	0.00207	CcSEcCtD
Valrubicin—Headache—Etoposide—testicular cancer	3.29e-05	0.00206	CcSEcCtD
Valrubicin—Flatulence—Doxorubicin—testicular cancer	3.29e-05	0.00206	CcSEcCtD
Valrubicin—Chest pain—Methotrexate—testicular cancer	3.28e-05	0.00206	CcSEcCtD
Valrubicin—Myalgia—Methotrexate—testicular cancer	3.28e-05	0.00206	CcSEcCtD
Valrubicin—Malaise—Epirubicin—testicular cancer	3.25e-05	0.00204	CcSEcCtD
Valrubicin—Discomfort—Methotrexate—testicular cancer	3.24e-05	0.00203	CcSEcCtD
Valrubicin—Back pain—Doxorubicin—testicular cancer	3.23e-05	0.00202	CcSEcCtD
Valrubicin—Nausea—Etoposide—testicular cancer	3.12e-05	0.00196	CcSEcCtD
Valrubicin—Ill-defined disorder—Doxorubicin—testicular cancer	3.09e-05	0.00194	CcSEcCtD
Valrubicin—Anaemia—Doxorubicin—testicular cancer	3.08e-05	0.00193	CcSEcCtD
Valrubicin—Myalgia—Epirubicin—testicular cancer	3.07e-05	0.00192	CcSEcCtD
Valrubicin—Chest pain—Epirubicin—testicular cancer	3.07e-05	0.00192	CcSEcCtD
Valrubicin—Discomfort—Epirubicin—testicular cancer	3.03e-05	0.0019	CcSEcCtD
Valrubicin—Malaise—Doxorubicin—testicular cancer	3.01e-05	0.00189	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Methotrexate—testicular cancer	2.86e-05	0.0018	CcSEcCtD
Valrubicin—Chest pain—Doxorubicin—testicular cancer	2.84e-05	0.00178	CcSEcCtD
Valrubicin—Myalgia—Doxorubicin—testicular cancer	2.84e-05	0.00178	CcSEcCtD
Valrubicin—Discomfort—Doxorubicin—testicular cancer	2.81e-05	0.00176	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Epirubicin—testicular cancer	2.68e-05	0.00168	CcSEcCtD
Valrubicin—Feeling abnormal—Methotrexate—testicular cancer	2.59e-05	0.00162	CcSEcCtD
Valrubicin—Gastrointestinal pain—Methotrexate—testicular cancer	2.57e-05	0.00161	CcSEcCtD
Valrubicin—Abdominal pain—Methotrexate—testicular cancer	2.48e-05	0.00156	CcSEcCtD
Valrubicin—Body temperature increased—Methotrexate—testicular cancer	2.48e-05	0.00156	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	2.48e-05	0.00156	CcSEcCtD
Valrubicin—Feeling abnormal—Epirubicin—testicular cancer	2.42e-05	0.00152	CcSEcCtD
Valrubicin—Gastrointestinal pain—Epirubicin—testicular cancer	2.41e-05	0.00151	CcSEcCtD
Valrubicin—Body temperature increased—Epirubicin—testicular cancer	2.33e-05	0.00146	CcSEcCtD
Valrubicin—Abdominal pain—Epirubicin—testicular cancer	2.33e-05	0.00146	CcSEcCtD
Valrubicin—Asthenia—Methotrexate—testicular cancer	2.26e-05	0.00141	CcSEcCtD
Valrubicin—Feeling abnormal—Doxorubicin—testicular cancer	2.24e-05	0.00141	CcSEcCtD
Valrubicin—Gastrointestinal pain—Doxorubicin—testicular cancer	2.23e-05	0.0014	CcSEcCtD
Valrubicin—Pruritus—Methotrexate—testicular cancer	2.22e-05	0.00139	CcSEcCtD
Valrubicin—Abdominal pain—Doxorubicin—testicular cancer	2.15e-05	0.00135	CcSEcCtD
Valrubicin—Body temperature increased—Doxorubicin—testicular cancer	2.15e-05	0.00135	CcSEcCtD
Valrubicin—Diarrhoea—Methotrexate—testicular cancer	2.15e-05	0.00135	CcSEcCtD
Valrubicin—Asthenia—Epirubicin—testicular cancer	2.11e-05	0.00132	CcSEcCtD
Valrubicin—Pruritus—Epirubicin—testicular cancer	2.08e-05	0.00131	CcSEcCtD
Valrubicin—Dizziness—Methotrexate—testicular cancer	2.08e-05	0.0013	CcSEcCtD
Valrubicin—Diarrhoea—Epirubicin—testicular cancer	2.01e-05	0.00126	CcSEcCtD
Valrubicin—Vomiting—Methotrexate—testicular cancer	2e-05	0.00125	CcSEcCtD
Valrubicin—Rash—Methotrexate—testicular cancer	1.98e-05	0.00124	CcSEcCtD
Valrubicin—Dermatitis—Methotrexate—testicular cancer	1.98e-05	0.00124	CcSEcCtD
Valrubicin—Headache—Methotrexate—testicular cancer	1.97e-05	0.00124	CcSEcCtD
Valrubicin—Asthenia—Doxorubicin—testicular cancer	1.95e-05	0.00122	CcSEcCtD
Valrubicin—Dizziness—Epirubicin—testicular cancer	1.95e-05	0.00122	CcSEcCtD
Valrubicin—Pruritus—Doxorubicin—testicular cancer	1.93e-05	0.00121	CcSEcCtD
Valrubicin—Vomiting—Epirubicin—testicular cancer	1.87e-05	0.00117	CcSEcCtD
Valrubicin—Nausea—Methotrexate—testicular cancer	1.87e-05	0.00117	CcSEcCtD
Valrubicin—Diarrhoea—Doxorubicin—testicular cancer	1.86e-05	0.00117	CcSEcCtD
Valrubicin—Rash—Epirubicin—testicular cancer	1.85e-05	0.00116	CcSEcCtD
Valrubicin—Dermatitis—Epirubicin—testicular cancer	1.85e-05	0.00116	CcSEcCtD
Valrubicin—Headache—Epirubicin—testicular cancer	1.84e-05	0.00116	CcSEcCtD
Valrubicin—Dizziness—Doxorubicin—testicular cancer	1.8e-05	0.00113	CcSEcCtD
Valrubicin—Nausea—Epirubicin—testicular cancer	1.75e-05	0.0011	CcSEcCtD
Valrubicin—Vomiting—Doxorubicin—testicular cancer	1.73e-05	0.00109	CcSEcCtD
Valrubicin—Rash—Doxorubicin—testicular cancer	1.72e-05	0.00108	CcSEcCtD
Valrubicin—Dermatitis—Doxorubicin—testicular cancer	1.71e-05	0.00108	CcSEcCtD
Valrubicin—Headache—Doxorubicin—testicular cancer	1.71e-05	0.00107	CcSEcCtD
Valrubicin—Nausea—Doxorubicin—testicular cancer	1.62e-05	0.00101	CcSEcCtD
